Skip to content

Intradialytic protein ingestion and exercise study

The effects of protein ingestion and exercise on plasma and dialysate amino acid concentrations during hemodialysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON27277
Enrollment
10
Registered
2018-07-10
Start date
2018-08-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialyse Hemodialysis Fysieke inspanning Exercise Eiwit Protein Aminozuren Amino Acids

Interventions

During four hemodialysis sessions, patients will (A) ingest a placebo drink, (B) ingest a placebo drink and perform aerobic exercise, (C) ingest a protein supplement, and (D) ingest a protein suppleme

Sponsors

Maastricht University Medical Centre+
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Aged >18 years - Ability to provide written informed consent - Hemodialysis treatment for >3 months - Well-functioning arteriovenous shunt in upper or lower arm

Exclusion criteria

Exclusion criteria: – Unstable cardiac status (i.e. cardiac ischemia) – Physical limitations affecting usage of the bike – Poor blood sugar control – Active infection or illness – Poorly functioning shunt – Previous episodes of intradialytic hypotension related to food intake – Hospitalization <3 months prior to study period – Missed hemodialysis session <1 month prior to study period – Allergies to milk protein

Design outcomes

Primary

MeasureTime frame
Primary study parameters are amino acid loss into the dialysate and plasma total amino acid concentrations.

Secondary

MeasureTime frame
Secondary study parameters are the loss of essential amino acids into the dialysate, plasma essential amino acids, glucose, and insulin concentrations, interstitial glucose concentrations, plasma and spent dialysate uremic toxin concentrations, and changes in blood pressure.

Contacts

Public ContactF.K. Hendriks

Maastricht Univeristy

f.hendriks@maastrichtuniversity.nl+31 43 388 1509

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)